OCYNTIO
Live / Applied — First extension granted (statement of use) (as of 05 Sept 2025)
What this means for you
Not registered yet, but its 09 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98491066
- Mark type
- Stylized text
- Filed
- 09 Apr 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infection-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical anti-allergic preparations and substances; vaccines
Owner
- Actelion Pharmaceuticals Ltd, Allschwil, CH
- Actelion Pharmaceuticals Ltd, Allschwil, CH
Prosecution history
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2025 — SOU EXTENSION 1 GRANTED
- 05 Sept 2025 — SOU EXTENSION 1 FILED
- 05 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Oct 2024 — ASSIGNED TO EXAMINER
- 17 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Apr 2024 — NEW APPLICATION ENTERED